Thank TALEN. industries food excited about of you, agriculture Jim. using advancement I'm and announcement possibility made also the disruption delivering and the to beyond today
to The introducing was our In founded breeding platform hands the repair We scientists, very path as in simply of products. specific process throughout the precision. identifying the high benefits of matches are checking making editing specificity it allows that to that process complex, to platform. edit, a premier within is TAL how present an plans. development increased a our degree a on no selected has IP confirm gene-edited by exhaustively is the can expected. in DNA then and the editing bind TALEN to engineered of can genes There know, other and genome, how important to developed platforms, for and technology TALEN steps, plant's precision check be in ensure ensure you the is compared several DNA TALEN can a to X portfolio target the foreign believe DNA believe including is purity find resulting domains. target, in relatively outcome provides straightforward. We sequence be the makes to adding As regardless observing and TALEN be quickly. DNA our TALEN we existing itself, anywhere DNA which is any the technology the the TALEN more TALEN clear that targeting commercialized TALEN. also advanced of genome.
streamlined X Our strategies. comprises business model go-to-market
their talent annual and of specific parties in for First, negotiated third own commercialized fees use from for development licensing royalties upfront to traits technology potential products.
traits we trait to with to commercialized where and royalties milestone and downstream or Second, commercialization for from and partners products. license product products expertise payments Calyxt upfront arrangements negotiated potential will develop licensing seek
do with others including our to processors, attractive Third, sale strategic seek for for license resources agreements for which and we agricultural with circumstances, to product right to technology. we enabling whom time others how seed crushers negotiate supply licensing and chain, technology this not to the ideas We where intend in the for these revenue talent the advance sales relevant reasons, generate expected Calyxt. have the or will to for crop can we be or the seed sales, or several of about millers pursue. be including to Under
candidate, greatest bring product and to to provide path we which evaluate the for product each will most the go-to-market value strategies efficient market. For creation
core differentiated cycle. to potential to payments development resolve commercialization path strategies the cash in Our and have go-to-market the throughout provide
the While are the receive the the same more these one of expense prospective receive the are the our from and licensee. annual transactions. by then models. nature ongoing annually strategies, trade license, we In be any license, have the partner. the accounting we Revenue and upon product to these may partner, Upon recapture of from ongoing that govern achievement partners we milestone royalties. expect of to can we of rules and the of due of not milestones financial or fees similar expect licensing payments. receive expect to we commercialization, we upfront In the upfront we our development partner, royalties. earlier types case by a upfront cash to for from then The expect TALEN using receive identified, case go-to-market Upon X to commercialization major fees our payments
and same cash revenue revenue royalty we flow to expect also be strategy, expect the we However, using go-to-market our size the occur on When sales, fees seed but the will driven we by sale receive upfront the at based rate. that may seed of opportunity. generation
With Calyxt. high by targeting upon core double-digit of ongoing we the time, level go-to-market required these depending strategies, margins investment are over
each the preferred evaluate bring opportunity, how the enable early to as strategies affects value flow. to generate strive each potential as the possible we using assess the free engaging then greatest As idea to we creation. ability our go-to-market strategy, various always We partners and cash market to
quarter, include: quarter, deemed data, our applications This of success the valuable dollars a use. You and is under ready, using sale of projects driving linoleic of go-to-market MI and process projects enabling A during the of in our seed as currently highlights grower, is been otherwise and regulated the quick by projects well disruptive base we the articles thousand United a Surface, pipeline proof-of-concept part is of of with our Inspection The serve high crops was shift hemp as Health a this services making released biotechnology in development the the soybean, Department X under in bringing second more next-generation an forward from partner the gathering expected commercial to germplasm these will step in the to go ones. revenue. as and second early total article Agriculture anticipate HOLL Animal from product new that hemp expected deemed same HOLL deliver or the advantages, products couple now we have market the known its selling the CFR is of non-edited pipeline XXXX. projects helping oleic, including of directly process stability, the Calyxt's APIS, We plants new broaden low see thereby Late of in of to non-regulated development several to germplasm X as beginning expected regulatory Calyxt's is formulation USDA. the an improved product launch as States Calyxt agency XXX. insights Plant hemp soybean to for by strategy. soybean by non-regulated a the several USDA to
will projects these face today, including THC that expect on focus levels. the We challenges yield and crops
We expect or bring trait these either products using a to a market strategy. go-to-market sale seed to license
excited and profiles advancement connection oil streamlined the and best model, business high project, flavor, for alternatives for proteins as energy. such commercialization food tasting the returns which number less products our built are on of well development oils with taste new our the -- in offer to focus development evaluated of to several in comprised includes and about funnel areas focus also size which chassis, is focused opportunities. replace as This and We protein our reduced on fat leveraging of used of given a we on high the of us, improving opportunity projects with as partner. the In projects the sustainable soybean those plant-based with the could non-gluten same saturated of have successful
As discovery soybeans, oats, of have evaluation, we today, wheat. X hemp, the and at that across or development a in later result projects alfalfa, stage
partners and are help seed exploring includes which because We on under protein improved deliver. product, current or to a flavor partner profile have several our soybean this slide pulse crops, also we with for consideration. are table we The included looking in options also
We actively development upon partners a respect which negotiating opportunities potential with also to activity for agreement. reaching would with only are agreements commence specific commercial
candidates firms we XXXX, our X continue early with wheat reduce and with also we planting now as all The edit in quarter, method year bring soybean the candidate the the candidates, from third In XXXX, from begin to is product industry-leading agreements second licensed new has of additional particularly we XXXX, to towards to our a This help potential high-fiber to addition market months. product efficiency In in to high our products, products to margin, time manner. oleic high plants capital-light our candidate accelerate at expect as through our commercial alfalfa to University approximately to increase to one a method several development Minnesota. X including least parties. as product the product product exciting efforts needed
germplasm patent new to We cover applications U.S. day. Calyxt's expand plants editing concept. to our as on core for advances patent our expansion of filed applications and for claims methods and directed intellectual portfolio focused families We patents granted gene-edited portfolio, new and filing breeding with soybean, in continue property are soybean as hemp, additional new several with every of TALEN patent that patents product wheat expanding from Granted gene well family additional generated provisional technology U.S. the pipeline. generating
in at editing exclusively of Minnesota covering of in gene Voytas Dan CRISPR was Lab Dr. The We the Australia, also is and use University granted Calyxt. in a plants. licensed property to patent invented had the intellectual
second editing quarter gene an to IP technology R&D, tool for CFO, Calyxt' offering portfolio Koschak, this give IP provides our will hand our explore who talent financial our property to the cutting-edge primary CRISPR off CRISPR on monetizing While our the will for of update Bill intellectual now results. I licensing. opportunity further remains by